//
MEDTRADE LLC is committed to conducting its business with integrity, transparency and responsibility.
Zero tolerance for bribery, corruption and improper payments
/ 02Lawful, transparent and merit-based business conduct
/ 03Ethical, transparent engagement with medical professionals
/ 04Lawful and ethical participation in procurement processes
/ 05Responsible handling of partner and business information
/ 06Privacy and personal data handled responsibly
/ 07Transparent management of competing interests
/ 08Ethical expectations for suppliers and partners
/ 09Traceability and quality across the supply chain
/ 10Open channel for compliance concerns
As a pharmaceutical company and integrated market access platform based in Uzbekistan, MEDTRADE recognizes that ethical business conduct is essential for trust, long-term cooperation and responsible development of the pharmaceutical market.
This page describes the main compliance and business ethics principles followed by MEDTRADE in its work with manufacturers, healthcare professionals, pharmacies, public and private institutions, suppliers, consultants, logistics partners, investors and other stakeholders.
MEDTRADE is committed to complying with applicable laws, regulations, ethical standards and internal business principles.
We expect our employees, representatives, consultants, partners and suppliers to act honestly, responsibly and in accordance with applicable legal and ethical requirements.
MEDTRADE does not tolerate corruption, bribery, fraud, improper influence, falsification of documents or unethical business practices.
MEDTRADE prohibits bribery, corruption and improper payments in any form.
Employees, representatives, consultants and partners acting on behalf of MEDTRADE must not offer, promise, give, request or accept any payment, benefit, advantage or anything of value intended to improperly influence a business, regulatory, medical, tender or official decision.
This principle applies to interactions with:
MEDTRADE supports fair and lawful competition.
We do not support anti-competitive practices, including price fixing, bid rigging, market allocation, collusion, misuse of confidential competitor information or other practices that violate competition rules.
Commercial decisions must be based on quality, service, lawful pricing, professional standards and legitimate business considerations.
MEDTRADE interacts with healthcare professionals only for professional, scientific, educational, informational and legitimate business purposes.
Any interaction with doctors, pharmacists, medical institutions or healthcare organizations must comply with applicable legal and ethical requirements.
MEDTRADE does not use unlawful payments, gifts, benefits or other improper incentives to influence medical decisions, product recommendations, prescriptions, procurement decisions or professional judgment.
Educational events, presentations, meetings and professional communications must have a legitimate purpose and must be conducted in an ethical and transparent manner.
MEDTRADE follows a responsible and cautious approach to gifts, hospitality and business courtesy.
Any hospitality, meeting, event or courtesy must be lawful, reasonable, transparent, modest and connected to a legitimate business or professional purpose.
No gift, hospitality or benefit may be offered or accepted if it is intended to improperly influence a decision or create a conflict of interest.
MEDTRADE participates in public and private procurement procedures only through lawful and ethical methods.
MEDTRADE does not tolerate:
All tender-related activities must be conducted in accordance with applicable procurement rules, documentation requirements and ethical standards.
MEDTRADE aims to conduct its activities in accordance with applicable pharmaceutical, regulatory, licensing, certification, distribution, advertising, import, storage and commercial requirements.
Regulatory, certification, legal and tender-related support may be provided through UZPHARMCONSULTING, within the scope of applicable laws and professional standards.
MEDTRADE recognizes the importance of quality, traceability and proper storage in pharmaceutical distribution.
The company supports GDP-based principles in pharmaceutical logistics, storage, documentation, temperature control, cold chain and responsible distribution.
Quality-related activities must be performed with accuracy, responsibility and respect for applicable standards and internal procedures.
MEDTRADE respects confidential business information received from partners, manufacturers, suppliers, consultants and other stakeholders.
Confidential information may include product data, commercial terms, regulatory documents, certificates, dossiers, pricing information, investment materials, technical information and business plans.
Such information must be used only for legitimate business purposes and must not be disclosed without proper authorization or agreement.
Where necessary, MEDTRADE may enter into a separate Non-Disclosure Agreement.
MEDTRADE respects privacy and personal data protection.
Personal information must be collected, used, stored and processed only for legitimate business, legal, regulatory, communication or cooperation-related purposes.
More information is available in the MEDTRADE Privacy Policy.
Employees, representatives, consultants and business partners should avoid situations where personal, financial or other interests may conflict with the interests of MEDTRADE or its partners.
Any actual or potential conflict of interest should be disclosed and managed transparently.
Business decisions must not be influenced by undisclosed personal interests, family relationships, private benefits or improper advantages.
MEDTRADE expects its partners, suppliers, consultants, agents, representatives and service providers to act in accordance with applicable laws, ethical standards and anti-corruption principles.
MEDTRADE may refuse cooperation or terminate cooperation with parties involved in bribery, corruption, fraud, illegal trade, falsification of documents, unethical promotion or other improper conduct.
MEDTRADE aims to communicate accurately, professionally and responsibly.
Information shared with partners, healthcare professionals, pharmacies, institutions and the public should be accurate, appropriate, lawful and not misleading.
Product-related communication must respect applicable regulatory requirements and approved product information.
MEDTRADE encourages employees, partners and other stakeholders to report concerns related to unethical conduct, corruption, bribery, conflict of interest, tender misconduct, confidentiality breaches or other compliance-related issues.
Reports may be sent to:
Reports will be reviewed with appropriate confidentiality and responsibility.
MEDTRADE does not support retaliation against persons who raise compliance concerns in good faith.
MEDTRADE understands that compliance is an ongoing process.
The company aims to continuously improve its internal standards, procedures, partner expectations and business practices in line with applicable law, market development and international pharmaceutical business standards.
For compliance-related questions, concerns or reports, please contact:
MEDTRADE LLC